Celebrity Inventors
Walt Disney was no Mickey Mouse inventor. He devised a serious animation camera which he patented. With the device, his company created "Snow White".
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7435732 | Crystalline polymorphs of (3S)-N-hydroxy-4-({4-[-(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide This invention relates to crystalline polymorphs of (3S)-N-hydroxy4-({4-[(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide, and preparation and uses thereof. ... | 10/14/2008 |
| 7381260 | Thiazineindigo pigment dispersant, and pigment composition, colored composition and color filter, using the same A thiazineindigo pigment dispersant represented by Formula (1) or (2): where E denotes a basic group. A pigment composition contains a pigment material, and the thiazine indigo pigment dispersant. A colored composition cont... | 06/03/2008 |
| 7333126 | Optical disc having layers corresponding to different colors and sensitive to optical beam wavelengths For at least some layers of a number of stacked layers of an optical disc that correspond to different colors, an optical beam is selectively impinged on a region of the optical disc. The optical beam has a wavelength to which the layer is uniquely sensitive as comp... | 02/19/2008 |
| 7323563 | Hydroxamic acid derivatives as antibacterials A method for the treatment of bacterial infections in humans and non-human mammals, which comprises inhibiting bacterial growth by administering to a subject an antibacterially effective dose of a compound of formula (I) or a pharmaceutically or veterinarily accepta... | 01/29/2008 |
| 7282496 | Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors Compounds of the formula are useful in treating disease conditions mediated by TNF-α, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease, degenera... | 10/16/2007 |
| 7183276 | Azole compounds The present invention provides a compound represented by the formula (I) wherein R1 is a hydrogen atom, a halogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocycl... | 02/27/2007 |
| 7179911 | Method for preparing hydroxamic acids Processes for using a compound of formula III: to make compounds of formulae I and II: and processes for making the compound of formula III, where R1-5 ... | 02/20/2007 |
| 7166590 | Amino acid derivatives A compound of the formula (I): [wherein R1 is (substituted) alkyl, alkoxy, phenyl, hetero ring etc.; A is bond, CO, SO2; R2 is H, (substituted) alkyl etc.; D is alkylene etc.; E is COO,... | 01/23/2007 |
| 7122675 | Gamma secretase inhibitors Novel aryl and heteroaryl sulfonamides are disclosed. The sulfonamides, which are gamma secretase inhibitors, are represented by the formula: wherein Ar1 and Ar2 independently represent aryl or he... | 10/17/2006 |
| 7022846 | Metabolites of prinomastat and their synthesis Metabolites of a matrix metalloproteinase inhibitor prinomastat and their synthesis. These metabolites are: (3S)-N-hydroxy-4-(4-((1-oxy-pyrid-4-yl)oxy)benzenesulfonyl)-2,2-dimethyl-tetrahydro-2H-1,4-thiazine-3-carboxamide (M6); (3S)-2,2-dimethyl-1,1-dioxo-4-[4-(1-ox... | 04/04/2006 |
| 6849732 | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation The invention relates to compounds of the formula 1: wherein: Z is O or S; V is a divalent radical which together with C* and N forms a ring having six ring atoms, where each of said ring atoms other than C* and... | 02/01/2005 |
| 6756372 | Compounds useful as reversible inhibitors of cysteine proteases Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds. ... | 06/29/2004 |
| 6685617 | Inhibitors of 댔댡 mediated cell adhesion The present invention relates to compound of formula (I), that are potent inhibitors of 댔ଲ.sub.1 mediated adhesion to either VCAM or CS-1 and which could be useful for the treatment of inflammatory diseases. Specifically, the molec... | 02/03/2004 |
| 6649771 | Silver halide color photographic light-sensitive material, pyrrolotriazole compound and dye-forming compound A pyrrolotriazole compound of the following formula (I), and a silver halide color photographic light-sensitive material containing the pyrrolotriazole compound as a cyan coupler: ##STR1## wherein R1 and R2 each independently are an ... | 11/18/2003 |
| 6599902 | 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors The present invention relates to certain 5-aralkylsulfonyl-3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives that inhibit kinases, in particular met kinase. Pharmaceutical compositions comprising these compounds, methods of treating diseases media... | 07/29/2003 |
| 6500948 | Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof The invention relates to compounds of the formula 1: ##STR1## wherein: Z is O or S; V is a divalent radical which together with C* and N forms a ring having six ring atoms, where each of said ring atoms other than C* and N independently is unsubstituted o... | 12/31/2002 |
| 6492421 | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 Disclosed are compounds which bind VLA-4. Certain of these compounds aslo inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g.... | 12/10/2002 |
| 6492394 | Sulfonamide hydroxamates A compound of the Formula (I): ##STR1## wherein Z, R1, R, and Ar2 are as defined in the specification. This invention also relates to sulfonamide compounds of the Formula (I) that are inhibitors of procollagen C-proteinase, pharmaceu... | 12/10/2002 |
| 6472404 | HIV protease inhibitors The present invention discloses novel isoquinoline carboxamide derivatives which are HIV protease inhibitors or prodrugs thereof, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the co... | 10/29/2002 |
| 6472527 | Process for the preparation of thiazine-indigo compounds and of new intermediates therefor New heterocyclic compounds are disclosed which are used as intermediates for the preparation of trans-thiazine-indigo pigments which are in part new compounds and can be used for the mass pigmentation of organic substrates. Also disclosed are different en... | 10/29/2002 |
| 6472526 | Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof The present invention relates to a novel imidazole derivative represented by formula (1) which shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in which A, n1 and Y are defined i... | 10/29/2002 |
| 6436980 | Peptidomimetic efflux pump inhibitors Compounds are described which have efflux pump inhibitor activity. Also described are methods of using such efflux pump inhibitor compounds and pharmaceutical compositions which include such compounds.... | 08/20/2002 |
| 6387896 | Bicyclic oxazolidinones as antibacterial agents The present invention provides compounds of formula I useful as antimicrobial agents ##STR1## wherein W, X, Y, R1, R2 and n are as defined in thereof.... | 05/14/2002 |
| 6384219 | 1H-pyrrolo-[1,2-b][1,2,4,]triazole compound and its synthetic intermediate, and method of preparing a 1H-1,2,4-triazole-5-yl-acetic acid ester compound There is disclosed a 1H-pyrrolo-[1,2-b][1,2,4]triazole compound represented by formula (I): ##STR1## wherein R is an alkyl group; R1, R2, R3, R1 ', R2 ', and R3 ' each are a hydrogen atom o... | 05/07/2002 |
| 6365587 | Substituted aryl hydroxamic acids as metalloproteinase inhibitors The present application describes novel substituted aryl hydroxamic acids of formula I: ##STR1## or pharmaceutically acceptable salt forms thereof, wherein ring A is a 5-8 membered ring containing from 0-1 additional heteroatoms selected from N, O, a... | 04/02/2002 |
| 6355640 | Pyrazolopyridine adenosine antagonists The present invention relates to a novel pyrazolopyridine compound of the following formula: ##STR1## wherein R1 is aryl, and R2 is cyclo(lower)alkyl which may have one or more suitable substituent(s), etc; and a pharmaceutically acc... | 03/12/2002 |
| 6310080 | Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors Selected amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, rela... | 10/30/2001 |
| 6303652 | BTK inhibitors and methods for their identification and use The invention provides BTK inhibitors, methods for their identification and use, and pharmaceutical compositions comprising BTK inhibitors.... | 10/16/2001 |
| 6268363 | Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof The present invention relates to a novel imidazole derivative represented by formula (1) which shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in which A, n1 and Y are defined i... | 07/31/2001 |
| 6265228 | Process for preparing combinatorial amide alcohol libraries Combinatorial chemical libraries of the Formula [S]--C(O)--L'--Z containing dihyroxy amides and hydroxyphosphonate amides are disclosed, in which [S] represents a solid support and --L'--Z is a linker/ligand residue. In these libraries, Z is ##STR1##... | 07/24/2001 |
| 6262060 | Azacycloalkane derivatives, preparation and therapeutic application The invention relates to azacycloalkane derivatives, to pharmaceutical compositions containing them, to processes for preparing them, and to methods for the treatment of hyperglycaemia, diabetes, obesity or inflammation utilizing them.... | 07/17/2001 |
| 6255305 | Substituted triazolo-pyridazine derivatives as ligands for GABA receptors Substituted triazolo-pyridazine derivative compounds represented by ##STR1## wherein the variables are disclosed herein are selective ligands for GABA-A receptors, particularly for the 댒 and/or 댓 subunits.... | 07/03/2001 |
| 6159973 | Aromatic amides, their preparation process, the compositions containing them and their use as pesticides The subject of the invention is the compounds of formula (I): Q(CH2)a --(X1)b --Q1 --Q2 --C(X2)--N(R1)(R2) (I) in which: Q represents an aryl ... | 12/12/2000 |
| 6153609 | Arylsulfonylamino hydroxamic acid derivatives A compound of the formula ##STR1## wherein n, X, R3, R4 and Q are as defined above, useful in the treatment of a condition selected from the group consisting of arthritis, cancer, tissue ulceration, macular degeneration, resteno... | 11/28/2000 |
| 6133290 | 5-HT1F agonists The present invention relates to a compound of formula I: ##STR1## or a pharmaceutical acid addition salt thereof; which are useful for activating 5-HT1F receptors and inhibiting neuronal protein extravasation in a mammal.... | 10/17/2000 |
| 6130220 | Sulfamide-metalloprotease inhibitors This invention relates to sulfamides of formula (I) ##STR1## that are inhibitors of metalloproteases, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.... | 10/10/2000 |
| 6127357 | N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides Piperazine derivatives of formula I ##STR1## and their pharmaceutically acceptable acid addition salts are 5-HT1A binding agents, particularly 5-HT1A antagonists and may be used, for example, as anxiolytics. In the formula A is ... | 10/03/2000 |
| 6121300 | Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts The present invention relates to compositions and methods for reversing advanced glycosylation end product-mediated cross-linking and protein aging. Accordingly, compositions are described which comprise thiazolium compounds substituted with heterocyclic ... | 09/19/2000 |
| 6117870 | Cyclic amide derivatives A cyclic amide derivative of formula (I): ##STR1## wherein R1 represents a substituted alkyl group, a substituted alkenyl group, a substituted amino group, a substituted alkoxyl group, a substituted alkylthio group, a substituted carbamoyl... | 09/12/2000 |
| 6080738 | Heterocyclic amide compounds and medicinal uses thereof A heterocyclic amide compound of the formula (I) ##STR1## wherein each symbol is as defined in the specification, a pharmacologically acceptable salt thereof, a pharmaceutical composition thereof and a pharmaceutical use thereof. The heterocyclic ami... | 06/27/2000 |
